International Clinical Trial: Identification, Translation, and Innovative Drug Development of Novel Biomarkers for Obesity-Related Metabolic Disorders

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119614) titled 'Identification, Translation, and Innovative Drug Development of Novel Biomarkers for Obesity-Related Metabolic Disorders' on Feb. 28.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Peking Union Medical College Hospital

Condition: Obesity-related metabolic diseases

Intervention: Metabolically unhealthy obesity (MUO) group:None Normal-weight metabolically obese (NWMO) group:None Normal-weight metabolically healthy (NWMH) group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: Metabolically unhealthy obesity (MUO) group...